AG
COGT icon

Algert Global’s Cogent Biosciences COGT Stock Holding History

Algert Global’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.84M Buy
125,073
+9,019
+8% +$316K 0.06% 544
2026
Q1 		$4.47M Sell
116,054
-111,808
-49% -$4.13M 0.07% 472
2025
Q4 		$8.09M Sell
227,862
-39,280
-15% -$1.1M 0.13% 279
2025
Q3 		$3.84M Sell
267,142
-596,924
-69% -$7.07M 0.06% 486
2025
Q2 		$6.2M Buy
864,066
+335,804
+64% +$1.86M 0.13% 261
2025
Q1 		$3.16M Buy
528,262
+184,027
+53% +$1.44M 0.08% 440
2024
Q4 		$2.69M Buy
344,235
+165,210
+92% +$1.65M 0.06% 507
2024
Q3 		$1.93M Buy
179,025
+21,991
+14% +$214K 0.05% 561
2024
Q2 		$1.32M Sell
157,034
-207,078
-57% -$1.57M 0.04% 600
2024
Q1 		$2.45M Buy
364,112
+8,542
+2% +$52.8K 0.1% 346
2023
Q4 		$2.09M Buy
355,570
+252,495
+245% +$1.93M 0.08% 402
2023
Q3 		$1M Sell
103,075
-700
-0.7% -$8.3K 0.05% 567
2023
Q2 		$1.23M Sell
103,775
-98,240
-49% -$1.13M 0.05% 583
2023
Q1 		$2.18M Buy
202,015
+8,355
+4% +$107K 0.1% 312
2022
Q4 		$2.24M Buy
193,660
+87,190
+82% +$1.08M 0.12% 261
2022
Q3 		$1.59M Buy
+106,470
New +$1.46M 0.1% 356

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Algert Global's COGT Position: Q2 2026 in Review

Algert Global increased its Cogent Biosciences (COGT) stake by 7.8% in Q2 2026, buying an estimated $316K and bringing the position to 125,073 shares worth $4.84M. The position accounts for 0.06% of the portfolio, ranked #544.

Algert Global first reported a position in COGT in Q3 2022 and has held it in 16 quarters since. The position peaked at $8.09M in Q4 2025. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Algert Global held 125,073 shares of Cogent Biosciences worth $4.84M as of Q2 2026.
  • Algert Global bought 9,019 Cogent Biosciences shares in Q2 2026, an estimated $316K.
  • Cogent Biosciences made up 0.06% of Algert Global's portfolio in Q2 2026, its #544 holding.
  • Algert Global first reported a position in Cogent Biosciences in Q3 2022 and has held it in 16 quarters since.
  • Algert Global's Cogent Biosciences position peaked at $8.09M in Q4 2025.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.